EUVIMEDEUVIMED entdecken
Open Access · CC0

Paradoxical dominant negative activity of an immunodeficiency-associated activating PIK3R1 variant

Patsy R Tomlinson, Rachel G Knox, Olga Perisic, Helen Su, Gemma V Brierley, Roger L Williams iD, Robert K Semple iD

eLife · 2025

DOI: 10.7554/elife.94420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Patsy R Tomlinson und 6 weiteren Autor:innen. Beteiligte Einrichtung: The University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Class Ia Phosphatidylinositol 3-Kinase, Immunologic Deficiency Syndromes, Growth Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Medical Research Council, Wellcome Trust, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PIK3R1 encodes three regulatory subunits of class IA phosphoinositide 3-kinase (PI3K), each associating with any of three catalytic subunits, namely p110α, p110β, or p110δ. Constitutional PIK3R1 mutations cause diseases with a genotype-phenotype relationship not yet fully explained: heterozygous loss-of-function mutations cause SHORT syndrome, featuring insulin resistance and short stature attributed to reduced p110α function, while heterozygous activating mutations cause immunodeficiency, attributed to p110δ activation and known as APDS2. Surprisingly, APDS2 patients do not show features of p110α hyperactivation, but do commonly have SHORT syndrome-like features, suggesting p110α hypofunction. We sought to investigate this. In dermal fibroblasts from an APDS2 patient, we found no increased PI3K signalling, with p110δ expression markedly reduced. In preadipocytes, the APDS2 variant was potently dominant negative, associating with Irs1 and Irs2 but failing to heterodimerise with p110α. This attenuation of p110α signalling by a p110δ-activating PIK3R1 variant potentially explains co-incidence of gain-of-function and loss-of-function PIK3R1 phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class Ia Phosphatidylinositol 3-KinaseImmunologic Deficiency SyndromesGrowth DisordersHumansFibroblastsMutationClass I Phosphatidylinositol 3-KinasesPrimary Immunodeficiency DiseasesSignal TransductionHypercalcemiaMetabolic DiseasesNephrocalcinosis

Stichwörter der Autor:innen

APDS2PIK3R1SHORT syndromegeneticsgenomicshumanimmunodeficiencyimmunologyinflammationinsulin resistancemousephosphoinositide 3-kinase

Substanzen

PIK3R1 protein, humanClass Ia Phosphatidylinositol 3-KinaseClass I Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • The University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom.
  • MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom.
  • The National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom.
  • MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
  • Laboratory of Clinical Immunology & Microbiology, Intramural Research Program, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, United States.
  • Department of Comparative Biomedical Science, The Royal Veterinary College, London, United Kingdom.

ORCID-Profile: Roger L Williams, Robert K Semple

Förderung

  • Medical Research Council
  • Wellcome Trust
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Tomlinson, P. R., Knox, R. G., Perisic, O., Su, H., Brierley, G. V., Williams, R. L., & Semple, R. K. (2025). Paradoxical dominant negative activity of an immunodeficiency-associated activating PIK3R1 variant. eLife. https://doi.org/10.7554/elife.94420

Vancouver

Tomlinson PR, Knox RG, Perisic O, Su H, Brierley GV, Williams RL, et al. Paradoxical dominant negative activity of an immunodeficiency-associated activating PIK3R1 variant. eLife. 2025. doi:10.7554/elife.94420

BibTeX
@article{Tomlinson2025,
  author = {Tomlinson, Patsy R and Knox, Rachel G and Perisic, Olga and Su, Helen and Brierley, Gemma V and Williams, Roger L and Semple, Robert K},
  title = {Paradoxical dominant negative activity of an immunodeficiency-associated activating PIK3R1 variant},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.94420}
}
Kostenlos starten →